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Summary: The specificity of substrates for measuring cystyl-amino peptidase activity in pregnant serum in the assess-
ment of placental function was studied, using £-cystine-di-j3-naphthylamide, L-cystine-bis-/?-nitroanilide,/,-cysteine-j3-
naphthylamide, and S-benzyl-i-cysteine-p-nitroanilide. The enzyme activity with S-benzyl-Z,-cysteine-/?-nitroanilide
increased more rapidly and markedly than with other substrates with advancing gestation. At term, the highest value
was obtained with S-benzyl-i-cysteine-p-nitroanilide, followed by £-cysteine-/J-naphthylamide and cystineamides.
The cystyl-amino peptidase activity with these substrates in pregnant serum was well correlated with the plasma
oestriol level.
In the serum of normal individuals and in patients with hepatic disease, the highest catalytic activity was obtained
with Z,-cysteine-/J-naphthylamide, followed by S-benzyl-Z,-cysteine-p-nitroanilide and cystineamides. In hepatic
disease, the enzyme activity with i-cysteine-jJ-naphthylamide was markedly increased, but that with other substrates
was only slightly enhanced.
In the placenta, brain, heart and liver, the highest catalytic activity was observed with S-benzyl-Z,-cysteine-p-nitro-
anilide and the enzyme activity pattern was similar to that in pregnant serum. However, in the kidney and small
intestine the enzyme activity was highest withi-cysteine-ß-naphthylamide, followed with S-benzyl-£-cysteine-p-nitro-
anilide and cystineamides.
The enzyme activity with S-benzyl-Zrcysteine-p-nitroanilide in various sera was inhibited by Co2"1", but that with
/,-cysteine^naphthylamide was stimulated by this ion. The purified oxytocinase has been reported to be inhibited by
Co24". Therefore, the present observations suggest high efficacy of S-benzyk£-cysteine-p-nitroanilide for measuring
oxytocinase activity for the assessment of placental function.
Vergleich von Substraten für die Bestimmung von Cystyl-Aminopeptidase im Serum bei Schwangerschaft, Leber-
erkrankungen und in verschiedenen Geweben
Zusammenfassung: Die Spezifität def Substrate L-Cystin-di-jS-naphthylamid, L-Cystin-bis-p-nitranilid, L-Cystein-
ß-naphthylämid und S^Benzyl-L-cystein-p-nitranilid zur Bestimmung von Cystyl-aminopeptidase im Serum Schwan-
gerer für die Beurteilung der Placentafunktiön wurde untersucht. Mit S-Benzyl-Z-cystein-p-nitranilid wurde mit fort-
schreitender Schwangerschaft ein schnellerer und deutlicherer Anstieg als bei Verwendung anderer Substrate beob-
achtet. Beim Geburtsteimin wurden die höchsten Werte mit S-Benzyl-i-cystein-p-nitranüid erhalten, gefolgt von
LrCystein-0-naphthylamid und den Cystinamiden. Die mit diesen Substraten erhaltenen Cystyl-Aminopeptidasewerte
im Serum Schwangerer korrelierten gut mit der östriolkonzentration im Plasma. Im Serum Gesunder und von Patienten
mit Lebererkrankungen wurde die höchste katalytische Aktivität mit L-Cystein-jS-naphthylamid erreicht, gefolgt von
S-Benzyl-//-cystein-p-riitranilid und den Cystinamiden. MitZr-Cystein-ß-naphthylamid zeigten sich bei Lebererkran-
kungen deutlich erhöhte, mit den anderen Substraten nur gering erhöhte katalytische Aktivitäten.
In Placenta, Gehirn, Herz und Leber wurde ähnlich den Ergebnissen im Schwangerenserum die höchste katalytische
Aktivität bei Venyendung von S-Benzyl-L-cystein-p-nitroanilid gemessen. In Niere und Dünndarm jedoch war die kata-
lytische Aktivität mit Z-Cysteinr)3-naphthylamid am höchsten, gefolgt von S-Benzyl-£-cystein-p-nitranalid und den
Cystinamiden.
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Die katalytische Aktivität in zahlreichen Seren wurde bei Messungen mit S-Benzyl-I-cystein-p-nitranilid durch Co*+
gehemmt, jedoch bei Messungen mit ,-Cystein-jJ-naphthylamid von diesem Ion stimuliert. Gereinigte Oxytocinase soll
von Co++ gehemmt werden. Deshalb weisen die vorgelegten Beobachtungen auf einen Vorzug von S-Benzyl-Zrcystein-
p-nitranilid zur Messung der Oxytocinase für die Beurteilung der Placentafunktion hin.
Introduction
Serum cystyl-amino peptidase (EC 3.4.11.3) catalytic
activity is known to increase with advancing gestation,
the highest levels being found at term (1—16). Serial
serum cystyl-amino peptidase estimations appear to be
helpful in the diagnosis of placental failure (17—20) and
the management of intrauterine fetal growth retardation
and fetal distress, etc (21-27), but there is some contro-
versy (28-32). This may be the consequence of differ-
ences in various methods used for the enzymes assay.
For the assay of cystyl-amino peptidase activity in serum
or plasma, cystineamides such as L-cystine-di-j3-naphthyl-
amide (33-38) and L-cystine-bis-p-nitroanilide (39—49)
have been used as substrate. Cysteineamides, e.g.
S-benzyl-Zrcysteine-j3-naphthylamide (50), ,-cysteine-
jS-naphthylamide (51) and S-benzyl-Zr-cysteine-p-nitro-
anilide (52-58) have also been used. Greater sensi-
tivity occurs with the cysteineamides compared with
the cystineamides. However, it remains to be clarified
as to which substrate is most useful for assessing pla-
cental function.
In this investigation, in order to obtain information con-
cerning the efficacy of substrates for measuring cystyl-
amino peptidase activity in the assessment of placental
function, the enzyme activity in various sera and tissues
was studied using L-cystine-di-jS-naphthylamide, L-cystine-
bis-p-nitroanilide, L-cysteine-/J-naphthylamide and S-
benzyl-L-cysteine-p-nitroanilide. The enzyme activity in
pregnant serum was also evaluated by comparison with
the serum oestriol level, which is a reliable index of the




I mmol/1 in 0.05 mol/1 cacodylate buffer at pH 6. £-Cystine-
di-0-naphthylamide (Sigma Chem. Co.) is dissolved in a small
amount of water by adding dropwise 1 mol/1 HCL Excess HC1
should not be used. Thereafter, the pH is brought to 6 with
NaOH. Cacodylate buffer, pH 6, and water are then added.
L-Cysteine-ß-naph thylamide solution
1.5 ml of L-cystine-di-/3-naphthylamide, 1 mmol/1 in 0.05
mol/1 cacodylate buffer, pH 6, is treated with 0.1 ml of 25
mmol/1 mercaptoethanol at 37 °C for 15 min. In the presence of
a thiol, such as mercaptoethanol or reduced glutathione,
£-cystine-di-0-naphthylamide is converted to jL-cysteine-0-
naphthylamide (51).
L-Cystine-bis-p-nitroanilide solution
Z.-Cystine-bis-p-nitroanilide (Nakarai Chem. Co.), 3.5 mmol/1
in acetone/methanol mixture (100 ml + 900 ml) (58).
S-Benzyl-L-cysteine-p-nitroanilide so lution
S^Benzyl-Zrcysteine-p-nitroanilide (Nakarai Chem. Co.) 6.9
mmol/1 in acetone/methanol (100 ml + 900 ml) (58).
p-Dimethylaminocinnamaldehyde.reagent, freshly prepared
before use.
p-Dimethyläminocinnamaldehyde (Nakarai Chem. Co.), 20 mg,
is dissolved in 20 ml of methanol and dimethyl sulfpxide (1 + 1)
mixed with 10 ml of mercaptoethanol (25 mmol/1) and 1.5 ml
1.0 ml of 2 mol/1 HC1 are added.
MethanolIdimethylsulfoxide reagent
Methanol and dimethyl sulfoxide (1 + 1) mixture, 20 ml is
mixed with 10 ml of mercaptoethanol (25 mmol/1) and 1.5 ml




Cystyl-amino peptidase assay in serum
a) With Zrcystine-di-0-naphthylamide or L-cysteine-/3-naphthyl-
amide: I-Cystine-di-^-naphthylamide (1 mmol/1 in 0.05 mol/1
cacodylate buffer, pH 6) solution 1.5 ml, is preincubated with
and without 0.1 ml of thiol solution (25 mmol/1 mercapto^
ethanol) at 37 °C for 15 min. A serum sample 0.05 ml is
mixed with the above solution and inbubated at 37 °C for
15 min. p-Dimethylaminocinnamaldehyde color reagent 2.0 ml
is then added. After 15 min, the absorbance is determined at
540 nm. For a control, the reaction mixture without serum is
similarly incubated. After incubation, p-dimethylaminocinnam-
aldehyde color reagent and serum sample are added. 0-Naphthyl-
amine standards, 0.5 and 1 Mg, are prepared in the reaction
mixture in the same way as the test sample, but without serum.
b) With Zrcystine-bis-p-nitroanilide or S-benzyl-Z,-cysteine-p-
nitroanilide: ,-Cystine-bis-p-nitroanilide (3.5 mmol/1) or S-
benzyl-L-cysteine-p-nitroanilide (6.9 mmol/1), 0.1 ml, is mixed
with 1.0 ml of tris (hydroxymethyl)aminomethane buffer (0.1
mol/1, pH 7.2) and incubated with 0.05 ml of serum at 37 °C
for 15-30 min, followed by addition of p-dimethylaminocinn-
amaldehyde color reagent 2.0 ml. After 15 min, the absorbance
is determined at 565 nm. For a control, the reaction mixture
without serum is similarly incubated. After incubation, p-dime-
thylaminocinnamaldehyde color reagent and serum specimen
are added. p-Nitroaniline standards, 5 and 10 Mg, are prepared
in the same reaction mixture as the test sample, but without
serum.
Alternately, after incubation of the reaction mixture 2.0 ml of
methanol-dimethyl sulfoxide mixture containing mercapto-
ethanol and HC1 without p-dimethylaminocinnamaldehyde is
added and the absorbance is determined at 405 nm. For a control,
the reaction mixture without serum is similarly incubated,
followed by addition of the above reagent and serum.
Cystyl-amino peptidase assay in tissues
Various wet tissues, 20^50 g, were homogenized injl^liter öf tris
(hydroxymethyl) aminomethane buffer (0.1 moi/1, pH 7.2). The
enzyme activity is measured as in the case of serum enzyme
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using 0.05 ml of tissue homogenate. After incubation, 0.4 ml of
250 g/1 trichloroacetic acid is added and the mixture is centri-
fuged at 3.000 rpm for 10 min. Supernatant, 1 ml, is mixed
with 2 ml of p-dimethylaminocinnamaldehyde color reagent and
15 min later absorbance is measured.
Calculation
Enzyme activity is expressed as moles of 0-naphthylamine or p-
nitroaniline liberated from the substrate per liter of serum or per
mg of tissue protein per minute at 37 °C.
Serum oestriol (total) assay
Ea-Riapackit (Radiochemical Center, England) was used according
to the manufacturer's instructions.
Protein determination
Protein in various tissue homogenates and serum was measured
by the biuret method (61).
p-nitroanilide (52, 53). However, higher activities have been
reported with acetone/methanol (100 ml + 900 ml) (58).
In this study, we confirmed this finding (tab. 1). With the
concentration of L-cystine-di-/3-naphthylamide, L-cysteine-
0-naphthylamide, Z-cystine-bis-p-nitroanilide and S-benzyl-£-
cysteineTp-nitroanilide used in this study, maximal enzyme activ-
ity was observed under the conditions of the present method.
Correlation between units of catalytic activity and amounts of
serum or tissue homogenate, or incubation time
Under the conditions of this method, with 0.025, 0.05, and 0.075
ml of serum or tissue homogenates, 0-naphthylamine orp-nitro-
aniline liberated from substrates was linearly correlated with
incubation time for as long as 45 min and also with the amounts
of serum or tissue homogenates, showing greater values with
cysteineamides than with the corresponding cystineamides.
Analytical variables
Effect ofpHon liberation of -naphthylamine or p-nitroaniline
from the substrates
The maximal rate of hydrolysis of the naphthylamine amides of
cystine and cysteine by serum or various tissue was observed at
about pH 6 under the conditions of the present method with
cacodylate, tris(hydroxymethyl)aminomethane-maleate, or
citrate-phosphate buffer (fig. 1). The maximal rate of hydrolysis
of the nitroaniline amides of cystine and cysteine by the peptid-
ases in serum or various tissues was found at about pH 7 (fig. 1).
Substrate concentration
Ethylene glycol monomethyl ether was used previously as a
solvent for jL-cystine-bis-p-nitroanilide and S-benzyl-L-cysteine-
Tab. 1. Comparison of solvents for the substrate in the measure-
ment of cystyl-amino peptidase activity.









1. Normal 9 1.34
2. Normal 9 1.84
3. Pregnancy 24 weeks 28.39
4. Pregnancy 30 weeks 55.11
5. Pregnancy 30 weeks 77.32
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Fig. 1. Effect of pH on 'liberation of ̂ -naphthylamine or p-mtrpanuine from naphthylamides and nitroanilides.
a) Substrates: L-cystine-di-^-naphthylamide (—-=-)
L^cystein^-naptithylamide (-—ô)
b) Substrates: /.-cystine-bis-^-nitroanib'de (- )
S-benzyl-Zrcysteine-p-nitroanilide (-—--)
• normal serum, ï pregnant serum, · hepatitis serum, á placental homogenate.
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Colour reactions of -naphthylamine or p-nitroanilme with p-
dimethylaminocinnamaldehyde
Originally, p-dimethylaminocinnamaldehyde was used for the
determination of various amines (62). In addition, p-dimethyl-
aminocinnamaldehyde was used for measuring 0-naphthylamine in
the assay of leucine aminopeptidase activity (63). For measuring
jfl-naphthylamine, previous workers used a p-dimethylaminocinn-
amaldehyde reagent consisting of 0.3 g of p-dimethylaminocinn-
amaldehyde in 1000 ml of ethanol containing 3.5 g HC1 (63).
In their system, a serum or plasma specimen less than 0.02 ml,
must be used, otherwise serum protein will be precipitated,
resulting in turbidity of the reaction mixture.
In this study, the p-dimethylaminocinnamaldehyde reagent was
improved by modifying the concentration of p-dimethylamino-
cinnamaldehyde and HC1 and by using a methanol-dimethyl
sulfoxide (1 + 1) mixture and mercaptoethanoL With this im-
proved reagent, 0-naphthylamine and p-nitroaniline in the assay
system were measured with greater sensitivity and without
turbidity of the reaction mixture (tab. 2). The color developed
is stable for at least 60 min. The maximal absorption of color
was obtained at 540 nm with 0-naphthylamine and 565 nm
with p-nitroaniline.
Measurement of p-nitroaniline with methanol/dimethylsulfoxide
reagent
p-Nitroaniline liberated from the substrate was determined after
the addition of methanol-dimethyl sulfoxide mixture containing
HC1 and mercapto ethanol without p-dimethylaminocinnamal-
dehyde to the reaction mixture. By this system, a simple and
sensitive assay can be carried out without turbidity of the reaction
mixture. When trichloroacetic acid is used to precipitate protein
in the reaction mixture (58), the molar absorptivity of p-nitro-
aniline is markedly reduced (tab. 3). The present method is more
sensitive and has the advantage of omitting centrifugation as
compared with the previous spectrophotometric end-point
method (58) (tab. 3).
The molar absorptivity of p-nitroaniline is not constant, but
depends on the conditions under which it is measured. It is
strongly concentration-dependent, and it is influenced by the
ionic strength of solution (64). In this study, it was observed
that when the p H of the solution was lowered the molar
absorptivity was markedly reduced. The pH value of the reac-
tion mixture of the present method was significantly higher
than that of Durham's method (58) (1.6 vs 1.1), and the molar
absorptivity was therefore higher.
Tab. 2. Comparison of the p-dimethylaminocinnamaldehyde
color reagent of previous workers (63) and that used in
the present method.
Tab. 3. Comparison of absorbance of p-nitroaniline in the





















Reagent ofMatsutani et al (63): 0.3 g p-dimethylaminocinn-
amaldehyde in 1000 ml of ethanol containing 3.5 g HCL
Present reagent: l g p-dimethylaminocinnamaldehyde in
1000 ml of methanol-dimethylsulfoxide (1 + 1) mixture con-
taining 3.3 g HC1 and 0.089 g mercaptoethanol.




















The reproducibility of the enzyme assay (with Z,-cysteine-0-
naphthylamide ç = 30, x" = 13-3, SD = 0.57, CV = 3.1%; with
S-benzyl-£-cysteine-p-nitroanilide ç = 10, ÷ = 145.3, SD = 3.0,
CV =2.1%) and recovery rate of/3-naphthylamine or p-nitro-
aniline added to serum (98 to 102%) were excellent. In the
presence of bilirubin in serum at concentrations up to 10 mg/dl,
color development was not significantly influenced when the
serum blank was used.
Correlation between results obtained by the present p-di-
methylaminocinnamaldehyde colorimetric or methanol/dimethyl
sulfoxide reagent method and the method based on the Bratton-
Marshall reaction
A good correlation between the results obtained by the present
colorimetric or methanol/dimethyl sulfoxide reagent method
and by the method with the Bratton-Marshall reaction (65) was
observed, indicating the reliability of the present method (fig. 2
and 3).
10 7020 30 40 50 .60
/3-Naphthylomine liberated (37°C)
(Bratton-Marshall reaction)
l/imol /mm º ]
Fig. 2. Correlation between results of hydrolysis of naphthyfc
amides obtained by the present colorimetric method and
the method with the Bratton-Marshall reaction.
Normal serum with A cystineamide and Ä cysteineamide.
Pregnant serum with · cystineamide and ï cysteineamide.
ç = 66, r = 99 (ñ < 0.001), y = 0.72x + 0.34.
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100
100 300 400200 300 0 100 200
p-Nitroonjline liberated (37°C) [/imol/min-l]
(Bratton- Marsha U reaction) (methanol/dimethyl sulfoxide reagent)
Fig. 3. Correlation between results of hydrolysis of nitroanilides obtained by the present method and the method with the Bratton-
Marshall reaction.
Normal serum with * cystineamide and Ä cysteineamide.
Pregnant serum with · cystineamide and ï cysteineamide.
a) ç = 74, r = 0.99 (ñ < 0.001), y = 0.99x + 0.73.
b) ç = 26, r = 0.99 (ñ < 0.001), y = 1.04x + 5.45.
Results
Cystyl-amino peptidase activity with various substrates
in pregnant serum
The enzyme activity with Z,-cystine-di-/J-naphthylamide or
jL-cysteine- -naphthylamide with advancing gestation, the
highest levels were observed at term, being about three
times the nonpregnant values, respectively. When L-
cysteine^jS-naphthylafnide was used, greater sensitivity
was observed, but the increasing rate was similar to that
withL-cystine-di- -naphthylamide (tab. 4). With//·
cystine-bis-/?-nitroanilide or S-benzyl-//-cysteine-/?-
nitroanilide, the enzyme activity was also significantly
increased with advancing gestation, and at term the
average values were about 8.5 and 34 times that of non-
pregnant controls, respectively.
The enzyme activity with S-benzyl-Z,-cysteine-p-nitro-
anilide started to increase at about 16 weeks of pregnancy.
However, the enzyme activity with the other three
Tab. 4. Cystyl-amino peptidase activity (37 °Q and oestriol level in serum of pregnant women and patients with hepatic disease
Enzyme activity,
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substrates started to increase at around 22 to 24 weeks
of pregnancy (tab. 4). At term, the highest enzyme activ-
ity was obtained with S-benzyl-L-cysteine-p-nitroanilide,
followed with Z,-cysteine-j3-naphthylamide, Z,-cystine-
bis-p-nitroanilide, and i-cystine-di-j3-naphthylamide.
Although the enzyme activities with these substrates
were different, these values were well correlated with
each other in pregnant serum (tab. 4).
Cystyl-amino peptidase activity in normal subjects and
subjects with hepatic disease
WithZ,-cysteine-j3-naphthylamide the enzyme activity
was greatly increased in acute or chronic hepatitis and
hepatic cirrhosis as compared with the levels observed
in normal subjects (tab. 4). The enzyme level in hepatic
cirrhosis was as high as that at term of pregnancy. How-
ever, with/,-cystine-di-/3-naphthylamide, i-cystine-bis-
p-nitroanilide and S-benzyl-L-cysteine-p-nitroanilide the
enzyme activity in the serum of patients with these
diseases was only slightly increased, and the average
levels of these substrates were significantly lower than
that in pregnant serum (tab. 4). In contrast to pregnant
serum, the highest enzyme levels in the serum of normal
subjects and those with hepatic disease were observed
with L-cysteine-jJ-naphthylamide, followed with S-benzyl-
i-cysteine-p-nitroanilide, L-cystine-bis-p-nitroanilide and
L-cystine-di-jS-naphthylamide.
Oestriol level in pregnant serum
The total oestriol level in serum started to increase at 20
to 24 weeks of gestation and the highest level was
observed at term, being about 39 times greater than the
value of nonpregnant serum (tab. 4).
Correlation between cystyl-amino peptidase activity and
oestriol level in pregnant serum
A good correlation was observed between the oestriol
level and the cystyl-amino peptidase activities, using L-
cystine-di-/3-naphthylamide,Z,-cysteine^-naphthyl·
amide, Æ,-cystine^bis-p-nitroanilide or S-benzyl-L-
cysteine^nitroanilide (fig. 4 and 5). The best correla-
tion was observed between the oestriol level and the
enzyme activity with S-benzyl-Z-cysteine-pi-nitroanilide.
Cystyl-amino peptidase activity in human placenta
and various rat tissues \
In the placenta, the enzyme activity with S-benzylrL-
cysteine-p-nitroanilide was the highest, followed by
L-cysteine-j3-naphthylamide,Z,icystine-bis-/7-nitroanilide
andZ,-cystine-di-j3-naphthylamide (tab. 5). A similar
pattern of enzyme activity was observed in various rat
tissues such as liver, brain, heart etc., but in the kidney
and small intestine the greatest enzyme activity was














, Serum oestriol [/ig/l]
100 200 300 400
Fig. 4. Correlation between cystyl-amino peptidase activity with cystineamides and oestriol levels in pregnant serum.
a) Substrate: Zrcystrne-di-0-naphthylamide
ç = 61, r = 0.81 (ñ < 0.001), y = 0.020x + 4.13.
b) Substrate: I-cystine-bis-p-nitroanilide
ç = 61, r = 0.81. (ñ < 0.001), y = 0.087x + 4.84.
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Fig. 5. Correlation between cystyi-amino peptidase activity with cysteineamides and oestriol levels in pregnant serum.
a) Substrate: Z,-cysteine-0-naphthylamide
ç = 61, r = 0.82 (ñ < 0.001), y = 0.06x + 15.29.
b) Substrate: S-benzyl-I-cysteinerp-nitroanilide
ç = 61, r = 0.87 (p < 0.001), y = 0.72x + 16.03.
Tab. 5. Cystyl-amino peptidase activity (37 °C) in human placenta and various rat tissues.
Enzyme activity, 0-naphthylamine or p-nitroaniline liberated



















































































with S*benzyl'L-cysteine-p-nitTQ2LW\ide and cystine-
amides.
Effect of heating, methionme, and Co2* on enzyme
activity
The effect of heat, rhethionine, and Co2* on the enzyme
activity was studied as described by previous workers
(66). The activity of cystyl-amino peptidase in various
sera with various substrates studied was inhibited by
heat and by methionine (tab. 6). The enzyme activity
with S^benzyl-jL-cysteine-^rmtroanilide was inhibited
by Co2+, while the enzyme activity with Z-cysteine-
j3-naphthylamide was stimulated by this ion (tab. 6).
Withl,-cystme-bis-p-nitroarulide, the enzyme activity
in sera of nonpregnant women and patients with hepatic
cirrhosis was inhibited by Co2+, but that in pregnant
sera was stimulated. With L-cystine-di- -naphthylamide,
the enzyme activity in these sera was not influenced by
Co2+.
Discussion
The cystyl-amino peptidase in the serum of pregnant
women was studied with L-cystine-di-/kiaphthylamide,
Zi-cystine-bis-/?-nitroanilide>/,-cysteine-j3-naphthyl-
amide and S-benzyl^-cysteine-p-nitroanilide. The
cystyl-amino peptidase activities measured with these
substrates were increased with advancing gestation,
the highest levels being obtained at term. The activity
J. Clin. Chem. Clin. Biochem. / Vol. 19, 1981 / No. 3
152 Uete, Motokura, Kitano, Fukutani, Uenishi and Ando: Comparison of substrates for measuring cystyl-amino peptidase activity
Tab. 6. Effect of heating, methionine and Co2"1" on cystyl-amino peptidase activity (37 °C) in serum.
I-Methionine and CoCl2 were used at a concentration of 20 and 0.5 mrnol/1 of the reaction mixture, respectively. Serum
was heated at 60 °C for 30 min just prior to the assay of enzyme activity. Figures in parentheses are remaining activity fractions
referred to the control values.
0-Naphthylamine or p-nitroaniline liberated [ìçºèÉ/min · 1]











































































































































































































with cysteineamides was greater than that with the
corresponding cystineamides. The increase in the enzyme
activity in normal pregnancy, using any of the above
substrates, followed the S-shaped curve, which previous
workers have described (14, 24). The increasing rate and
the range of the enzyme activities were different for each
substrate used. This difference is very important in the
clinical assessment of placental function. The enzyme
activity with S-benzyl-L-cysteine-p-nitroanilide
started to increase at about 16 weeks of gestation,
while the enzyme activity with the other three sub-
strates started to increase at about 22 to 24 weeks. The
rate of increase of enzyme activity with S-benzyl-Z,-
cysteine-p-nitroanilide was far greater than with other
substrates with advancing gestation, At term, the
highest enzyme activity was obtained with S-benzyl-
L-cysteine-p-nitroanilide, followed byZ,-cysteine-/3-
naphthyl mide and cystineamides. However, the
enzyme levels with these substrates correlated well,
thus confirming the previous studies (47, 49, 55). In
contrast, in sera of healthy nonpregnant females and
males, the enzyme activity was the highest with I-
cysteine-0-naphthylamide, followed by S^benzyl-
£-cysteine-/7-nitroanilide and cystinearnides.
The urinary excretion pattern of oestriol is useful
for evaluating normal and abnormal pregnancy (67,
6$), although the precise meaning and usefulness of
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oestriol measurement during pregnancy remain contro-
versial. Clinically, a decline in oestriol excretion may
indicate a failing feto-placental unit, whereas a normal
value generally indicates fetal well being. Similarly,
the plasma oestriol concentration provides a ready
indication of the functional status of the feto-placental
units in the absence of renal failure (59, 60). It has
suggested that plasma oestriol values would be more
useful for determining feto-placental viability than the
corresponding urinary measurement (69-71). Although
previous studies have shown correlation between the
urinary oestrogen levels and the serum cystyl-amino
peptidase activity (21, 22, 28, 29, 72-74), it is not
well understood with respect to the relationship
between the serum cystyl-amino peptidase activity and
the plasma oestriol level. In this study, therefore, the
plasma oestriol level and the cystyl-amino peptidase
activity with various substrates were studied simul-
taneously in pregnancy. Serum oestriol in pregnancy
gradually increased with advancing gestation, which
correlated with increased cystyl-amino peptidase
activity. It was very markedly increased at the third
trimester. All cystyl-amino peptidase activities measured
with four substrates correlated well with the plasma
oestriol levels, but the best correlation was observed
between the oestriol level and the cystyl-amino peptid-
ase activity with S-benzyl-L-cysteine-p-nitroanilide.
In the senim of hepatic disease such as hepatitis and
hepatic cirrhosis, the cystyl-amino peptidase activity is
reported to be increased (66). In this study the cystyl-
amino peptidase activity in the serum of hepatic disease
was increased with all four substrates. The enzyme
activity withZ-cysteine-j3-naphthylamide was greatly
increased* but that with S-benzyl-Z,-cysteine-p*nitn>
anilide and cystineamides was not so markedly increased.
Since the enzyme activity in the liver was the highest
with S-benzyl-t-cysteine-p-nitroanilide, followed by
Z,-cysteine-£naphthylamide, then cystineamides, the
present serum enzyme pattern of hepatic disease suggests
that in hepatic disease the enzyme hydrolyzing L-
cysteine-^naphthylamide was more permeable to the
hepatic cell membrane than the enzyme hydrolyzing
SAenzyl^-cysteine-p-nitroanilide. Likewise, in serum
of nonpregnant healthy individuals, the highest serum
enzyme value was obtained with Z/-cysteine-j3-naphthyl-
amide.
In contrast, in pregnant serum cystyl-aminp peptidase
activity with S-benzyl-£-cysteine-p-nitroanilide was far
greater than that with jL-cysteine^-naphthylamide. The
enzyme activity pattern of pregnant serum with these
different substrates was quite similar to that in the
placental tissue, in which the highest value was obtained
with S-benzyl-L-cysteine-p-nitroanilide. This supports
the view that the eystykamino peptidase activity in
pregnant serum probably originates from the placenta,
äs previously suggested (5, 75, 76).
A question arises with respect to the mechanism of
hydrolysis of these substrates by serum and various
tissue homogenates. Under the conditions of this study,
in various sera and tissue homogenates the maximal
activity of enzyme hydrolyzing S-benzyl-L-cysteine-p-
nitroanilide was observed at about pH 7.0 and that of
enzyme hydrolyzing £-cysteine-j3-naphthylamide was at
about pH 6 in cacodylate, tris-maleate or citrate-phos-
phate buffer. The enzyme activity with S-benzyl-L-
cysteine-p-nitroanilide in various sera was inhibited by
Co2"1", but that withZ,-cysteine-j3-naphthylamide was
stimulated by this ion. With L-cystine-bis-p-nitroanilide
the enzyme activity in serum of nonpregnant women and
patients with hepatic cirrhosis was inhibited by Co2+, but
that in pregnant serum was enhanced by this ion. With
i-cystine-di-jS-naphthylamide, the enzyme activity of
various sera was not influenced by Co2+. Tiderström
&Heinegard (66) have showed the inhibiting effect
of Co2"1" on the enzyme activity with S-benzyl-L-
cysteine-p-nitroanilide. Furthermore, they demon-
strated that the enzyme activity with L-cystine-bis-p-
nitroanilide in serum of nonpregnant women and
patients with hepatic disease was inhibited by this ion,
whereas that in pregnant serum was stimulated. The
present study confirmed this finding. These results
together indicate some difference in the mechanism
of the hydrolysis of these substrates by serum,
suggesting that the cystyl-amino peptidase activity
determined with synthetic substrates not only measures
oxytocinase, but is also influenced by some other
amino peptidase of uncertain origin. The purified
oxytocinase activity was reported to be inhibited by
Co2+ by Tuppy & Wintersberger (77). Since in this
study the enzyme activity with S-benzylrL-cysteine-
p-nitroanilide in various sera was uniformly inhibited
by Co2+, S-benzyl-L-cysteine-/?-nitroanilide may be a
more reliable substrate for measuring oxytocinase in
serum or tissues. ;
Because of the presence of various proteases or amidases
in serum, the absence of specificity of substrate is impor-
tant. Although absolute substrate differentiation for
measuring cystyl-amino peptidase activity in serum
cannot be expected (78), evidence assembled in this
study suggests high efficacy of S-benzyl-L-cysteine-
p-nitroanilide for measuring serum cystyl-amino
peptidase for the assessment of placenta! function. How-
ever, further study is necessary, since a very few clinical
studies are available at present with respect to the serum
enzyme activity with this substrate.
The proposed method in this study is sensitive and
simpler than the previous colorimetric and spectro-
photometric methods. The present method does not
employ centrifugation and uses a single color reagent.
In addition, this method has the advantage that it can
be performed without using a reaction rate analyzer
or other sophisticated equipment.
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